Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation

Sponsor
Kardium Inc.
Study ID
NCT07651852
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Globe Pulsed Field System — DEVICE
    Ablation and atrial mapping with the Globe Pulsed Field System

Study Details

This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).

Key Dates

First listed
Jun 16, 2026
Start date
Jul 31, 2026
Status verified
Jun 2026
Primary completion
Oct 31, 2029
Completion
Oct 31, 2029

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: Globe Pulsed Field System

Primary Outcome Measure

Effectiveness endpoint [ Time Frame: 12 months ]

Central Contacts

Find similar trials

Nationwide
Atrial fibrillation trialsCardiology trialsHeart disease trials

Related Studies